Is Tesla Stock Overvalued or a Buy for the Next Decade?
Shares of EV major Tesla (NASDAQ:TSLA) have experienced extreme volatility…
Sell
28
BBIO Quote, Financials, Valuation and Earnings
Last price:
$32.24
Seasonality move
:
19.8%
Day range:
$32.97 - $33.93
52-week range:
$21.62 - $39.54
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
49.08x
P/B ratio:
--
Volume:
1.6M
Avg. volume:
3M
1-year change:
18.47%
Market cap:
$6.3B
Revenue:
$221.9M
EPS (TTM):
-$3.53
Earnings Data
Next earnings date for BBIO
Aug 01
2025
Most recent earnings per share
-$0.88
Beat by $0.12
(Apr 29/2025)
Consensus Estimate
-$1.00
(Apr 29/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
BBIO Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 08/01/2025 | Q2 | $100.4M | -- | -- | -$0.32 | -- |
| 04/29/2025 | Q1 | $57.7M | $116.6M | -$0.88 | -$1.00 | $0.12 |
| 02/20/2025 | Q4 | $4M | $5.9M | -$1.40 | -$1.09 | -$0.31 |
| 11/12/2024 | Q3 | $3.4M | $2.7M | -$0.86 | -$0.86 | -- |
| 08/01/2024 | Q2 | $4.5M | $2.2M | -$0.39 | -$0.94 | $0.55 |
| 05/02/2024 | Q1 | $83.8M | $211.1M | -$0.20 | -$0.54 | $0.34 |
| 02/22/2024 | Q4 | $3.8M | $1.7M | -$0.96 | -$0.80 | -$0.16 |
| 11/02/2023 | Q3 | -- | -- | -$1.08 | -$0.89 | -$0.19 |
| 08/03/2023 | Q2 | -- | -- | -$0.98 | -$0.88 | -$0.11 |
| 05/04/2023 | Q1 | -- | -- | -$0.92 | -$0.83 | -$0.09 |
| 02/23/2023 | Q4 | -- | -- | -$0.92 | -$0.94 | $0.02 |
| 11/03/2022 | Q3 | -- | -- | -$0.93 | -$1.01 | $0.08 |
| 08/04/2022 | Q2 | -- | -- | -$0.07 | -$0.86 | $0.79 |
| 05/05/2022 | Q1 | -- | -- | -$1.35 | -$1.10 | -$0.25 |
| 02/24/2022 | Q4 | -- | -- | -$1.01 | -$0.91 | -$0.10 |
| 11/04/2021 | Q3 | -- | -- | -$1.06 | -$0.91 | -$0.15 |
| 08/05/2021 | Q2 | -- | -- | -$0.66 | -$0.89 | $0.23 |
| 05/06/2021 | Q1 | -- | -- | -$1.18 | -$0.75 | -$0.43 |
| 02/25/2021 | Q4 | -- | -- | -$1.01 | -$0.86 | -$0.15 |
| 11/05/2020 | Q3 | -- | -- | -$0.98 | -$0.89 | -$0.09 |
| 08/11/2020 | Q2 | -- | -- | -$1.03 | -$0.73 | -$0.30 |
| 05/13/2020 | Q1 | -- | -- | -$0.78 | -$0.70 | -$0.08 |
| 03/02/2020 | Q4 | -- | -- | -$0.62 | -$0.63 | $0.01 |
| 11/07/2019 | Q3 | -- | -- | -$0.51 | -$0.54 | $0.03 |
| 08/14/2019 | Q2 | -- | -- | -$0.71 | -$0.40 | -$0.31 |
| 03/31/2019 | Q1 | -- | -- | -$0.51 | -- | -- |
| 12/31/2018 | Q4 | -- | -- | -$0.42 | -- | -- |
| 09/30/2018 | Q3 | -- | -- | -$0.34 | -- | -- |
| 06/30/2018 | Q2 | -- | -- | -$0.33 | -- | -- |
| 03/31/2018 | Q1 | -- | -- | -$0.40 | -- | -- |
BridgeBio Pharma Earnings Questions
-
How Much did BridgeBio Pharma Generate in Revenue Last Quarter?
BridgeBio Pharma reported $116.6M worth of top line sales in its most recent quarter.
-
Did BridgeBio Pharma Beat Earnings Last Quarter?
BridgeBio Pharma announced earnings per share of -$0.88 which represents a beat of analyst forecast a -$1.00 per share.
-
Is BridgeBio Pharma Profitable?
BridgeBio Pharma reported $114M that represents $0.60 per share over the last quarter.
-
What is the Analyst Consensus for BridgeBio Pharma EPS Next Year?
BridgeBio Pharma's earnings are forecast to decrease from -$2.88 per share to -$2.39 per share next year representing a decrease of -5.02%.
-
When is BridgeBio Pharma's Earnings Date?
BridgeBio Pharma's next earnings date is August 1, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Apple Stock Undervalued or Overvalued?
For many years, Apple (NASDAQ:AAPL) was just about the perfect…
Where Will Palo Alto Networks Stock Be in 5 Years?
You know those companies that just refuse to slow down…
Stock Ideas
Buy
70
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 39x
Buy
68
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 46x
Sell
39
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Buy
58
TNXP alert for May 28
Tonix Pharmaceuticals Holding [TNXP] is up 1.57% over the past day.
Sell
37
ATS alert for May 28
ATS [ATS] is down 1.27% over the past day.
Buy
88
SMR alert for May 28
NuScale Power [SMR] is down 0.37% over the past day.
